Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/109239
Title: Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA
Authors: Léveillé, Nicolas
Melo, Carlos A. 
Rooijers, Koos
Díaz-Lagares, Angel
Melo, Sonia A.
Korkmaz, Gozde
Lopes, Rui
Moqadam, Farhad Akbari
Maia, Ana R
Wijchers, Patrick J.
Geeven, Geert
den Boer, Monique L.
Kalluri, Raghu 
de Laat, Wouter
Esteller, Manel
Agami, Reuven 
Issue Date: 27-Mar-2015
Publisher: Springer Nature
Project: SFRH/BD/33472/2008 
SFRH/BD/74476/2010; POPH/FSE) 
Human Frontiers Program to S.A.M 
Netherlands Organization for Scientific Research (‘NWO’ Vidi grant) to M.L.dB. 
F.A.M., ‘Sara Borrell’ postdoctoral contract (CD12/00738) from the ISCIII at the Spanish Ministry of Economy and Competitiveness to A.D.L., European Research Council (ERC) Advanced Grant EPINORC (# 268626) to M.E. 
European Research Council (ERC) Advanced Grant EnhReg to R.A. 
Serial title, monograph or event: Nature Communications
Volume: 6
Issue: 1
Abstract: p53 binds enhancers to regulate key target genes. Here, we globally mapped p53-regulated enhancers by looking at enhancer RNA (eRNA) production. Intriguingly, while many p53-induced enhancers contained p53-binding sites, most did not. As long non-coding RNAs (lncRNAs) are prominent regulators of chromatin dynamics, we hypothesized that p53-induced lncRNAs contribute to the activation of enhancers by p53. Among p53-induced lncRNAs, we identified LED and demonstrate that its suppression attenuates p53 function. Chromatin-binding and eRNA expression analyses show that LED associates with and activates strong enhancers. One prominent target of LED was located at an enhancer region within CDKN1A gene, a potent p53-responsive cell cycle inhibitor. LED knockdown reduces CDKN1A enhancer induction and activity, and cell cycle arrest following p53 activation. Finally, promoter-associated hypermethylation analysis shows silencing of LED in human tumours. Thus, our study identifies a new layer of complexity in the p53 pathway and suggests its dysregulation in cancer.
URI: https://hdl.handle.net/10316/109239
ISSN: 2041-1723
DOI: 10.1038/ncomms7520
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Show full item record

Page view(s)

24
checked on Jul 17, 2024

Download(s)

15
checked on Jul 17, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons